Loading clinical trials...
Loading clinical trials...
Effect of Calcipotriol Plus Betamethasone Dipropionate Topical Suspension on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 17 Years) With Scalp Psoriasis
Conditions
Interventions
LEO 80185 (Taclonex® Scalp topical suspension/Xamiol® gel)
Locations
6
United States
Rady Children's Hospital San Diego
San Diego, California, United States
Leavitt Medical Associates of Florida, Inc.
Jacksonville, Florida, United States
Leavitt Medical Associates of Florida, Inc.
Ormond Beach, Florida, United States
Peachtree Dermatology Associates, PC
Atlanta, Georgia, United States
Deaconess Clinic
Evansville, Indiana, United States
Skin Specialists, PC
Omaha, Nebraska, United States
Start Date
April 1, 2010
Primary Completion Date
August 1, 2012
Completion Date
October 1, 2012
Last Updated
March 11, 2025
NCT05969223
NCT01195831
NCT06015152
NCT00400725
NCT00881868
NCT03331523
Lead Sponsor
LEO Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions